Page last updated: 2024-12-10

oxychlorosene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3084036
SCHEMBL ID156580
MeSH IDM0069365

Synonyms (17)

Synonym
unii-3214m86b2n
3214m86b2n ,
oxychlorosene [usan]
monoxychlorosene
oxychlorosene
clorpactin xcb
8031-14-9
oxychlorosene [mi]
oxychlorosene [mart.]
clorpactin
oxychlorosene [vandf]
oxychlorosene [who-dd]
warexin
SCHEMBL156580
DTXSID40230248
hypochlorous acid;4-tetradecylbenzenesulfonic acid
Q27256112

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The endpoints observed included blood flow rates and associated venous pressures, overall and device-related adverse events, the need for thrombolytic infusions, device-related infections (DRIs) and associated hospitalizations, and technical device survival."( Efficacy and safety results with the LifeSite hemodialysis access system versus the Tesio-Cath hemodialysis catheter at 12 months.
Caridi, JG; Hakki, FZ; Jackson, J; Kapoian, T; Martin, SP; Moran, J; Pedan, A; Reese, WJ; Rosenblatt, M; Ross, J; Ross, JP; Rushton, F; Schwab, SJ; Soundararajan, R; Stainken, B; Weiss, MA; Work, J; Yegge, J, 2006
)
0.33
" Patients in the LifeSite group experienced a significantly lower rate of non-device-related adverse events (P < ."( Efficacy and safety results with the LifeSite hemodialysis access system versus the Tesio-Cath hemodialysis catheter at 12 months.
Caridi, JG; Hakki, FZ; Jackson, J; Kapoian, T; Martin, SP; Moran, J; Pedan, A; Reese, WJ; Rosenblatt, M; Ross, J; Ross, JP; Rushton, F; Schwab, SJ; Soundararajan, R; Stainken, B; Weiss, MA; Work, J; Yegge, J, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (68.63)18.7374
1990's3 (5.88)18.2507
2000's5 (9.80)29.6817
2010's1 (1.96)24.3611
2020's7 (13.73)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.87 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index5.55 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.27 (0.95)

This Compound (36.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (7.84%)5.53%
Reviews3 (5.88%)6.00%
Case Studies2 (3.92%)4.05%
Observational0 (0.00%)0.25%
Other42 (82.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]